Generic Name: fostemsavir

Pronunciation: N/A

Abbreviation: N/A

Other Market Name: N/A

Drug Class: Entry Inhibitors

Company: ViiV Healthcare

Approval Status: Experimental

Generic Version Available: No

Experimental Code: BMS-663068


Drug Recommendation

Fostemsavir has not yet been reviewed for inclusion in the DHHS list of recommended HIV treatments.


General Info

Fostemsavir is an experimental HIV medication. It is in a category of HIV medicines called attachment inhibitors. It is currently in Phase III clinical trials. Fostemsavir targets a different step of the viral lifecycle and may be an option for indiviuals with virus that has become highly resistant to other HIV drugs.

Fostemsavir must be used in combination with other HIV drugs.


Dosage

Dosing Info:

N/A


Side Effects

N/A


Other Info

https://www.poz.com/article/fostemsavir-offers-hiv-treatment-hope-options


Last Reviewed: September 25, 2018